The Art of Medicine: Clinical Considerations for Patients With Advanced RCC - a podcast by Clinical Care Options
from 2020-09-21T20:20:05
In this episode, an expert medical oncology panel led by Elizabeth R. Plimack, MD, MS, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses clinical pearls for the management of patients with metastatic renal cell carcinoma (RCC). Topics include:
- Treating beyond progression with immunotherapy
- Management of patients with less common histologic subtypes of RCC
- Potential biomarkers for RCC
- Adverse event management
Presenters:
Elizabeth R. Plimack, MD, MS
Chief, Division of Genitourinary Medical Oncology
Director, Genitourinary Clinical Research
Professor, Department of Hematology/
Oncology
Fox Chase Cancer Center
Temple Health
Philadelphia, Pennsylvania
Brian A. Costello, MD
Associate Professor of Oncology and Urology
Division of Medical Oncology
Mayo Clinic
Rochester, Minnesota
Martin H. Voss, MD
Clinical Director, Genitourinary Medical Oncology Service
Memorial Sloan Kettering Cancer Center
Assistant Professor
Weill Cornell Medical College
New York, New York
Content based on an online CME program supported by educational grants from Eisai, Exelixis, and Pfizer and EMD Serono.
Link to full program:
https://bit.ly/32IS9gx
Further episodes of CCO Oncology Podcast
Further podcasts by Clinical Care Options
Website of Clinical Care Options